Table of Contents
February 15, 2022; Volume 19,Issue 2
A
An, Na
- You have accessSystematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cellsYu Yu, Minzhen Tao, Libin Xu, Lei Cao, Baoyu Le, Na An, Jilin Dong, Yajie Xu, Baoxing Yang, Wei Li, Bing Liu, Qiong Wu, Yinying Lu, Zhen Xie and Xiaohua LianCancer Biology & Medicine February 2022, 19 (2) 229-252; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0560
B
Bi, Jinghao
- You have accessGlobal pattern and trends of colorectal cancer survival: a systematic review of population-based registration dataYufei Jiang, Huiyun Yuan, Zhuoying Li, Xiaowei Ji, Qiuming Shen, Jiayi Tuo, Jinghao Bi, Honglan Li and Yongbing XiangCancer Biology & Medicine February 2022, 19 (2) 175-186; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0634
C
Cao, Lei
- You have accessSystematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cellsYu Yu, Minzhen Tao, Libin Xu, Lei Cao, Baoyu Le, Na An, Jilin Dong, Yajie Xu, Baoxing Yang, Wei Li, Bing Liu, Qiong Wu, Yinying Lu, Zhen Xie and Xiaohua LianCancer Biology & Medicine February 2022, 19 (2) 229-252; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0560
Chen, Yiyu
- You have accessThe advance of adjuvant treatment for triple-negative breast cancerJingyu Ge, Wenjia Zuo, Yiyu Chen, Zhiming Shao and Keda YuCancer Biology & Medicine February 2022, 19 (2) 187-201; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0752
D
Davidson, Nancy E.
- You have accessUpdates in endocrine therapy for metastatic breast cancerPoorni M. Manohar and Nancy E. DavidsonCancer Biology & Medicine February 2022, 19 (2) 202-212; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0255
Ding, Kefeng
- You have accessEfficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancerXinyi Zhou, Qian Xiao, Dongliang Fu, Haochen Zhang, Yang Tang, Jinjie He, Yeting Hu, Xiangxing Kong, Fei Teng, Xiangrui Liu, Ying Yuan and Kefeng DingCancer Biology & Medicine February 2022, 19 (2) 213-228; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0532
Ding, Yuwei
- You have accessErratum to A truncated protein product of the germline variant of the DUOX2 gene leads to adenomatous polyposisMengyuan Yang, Yingxin Zhao, Yuwei Ding, Juan Wang, Yinuo Tan, Dong Xu and Ying YuanCancer Biology & Medicine February 2022, 19 (2) 263; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.1213
Dong, Jilin
- You have accessSystematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cellsYu Yu, Minzhen Tao, Libin Xu, Lei Cao, Baoyu Le, Na An, Jilin Dong, Yajie Xu, Baoxing Yang, Wei Li, Bing Liu, Qiong Wu, Yinying Lu, Zhen Xie and Xiaohua LianCancer Biology & Medicine February 2022, 19 (2) 229-252; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0560
Du, Guanhua
- You have accessTumorigenic bacteria in colorectal cancer: mechanisms and treatmentsSha Li, Jinyi Liu, Xiangjin Zheng, Liwen Ren, Yihui Yang, Wan Li, Weiqi Fu, Jinhua Wang and Guanhua DuCancer Biology & Medicine February 2022, 19 (2) 147-162; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0651
F
Fu, Dongliang
- You have accessEfficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancerXinyi Zhou, Qian Xiao, Dongliang Fu, Haochen Zhang, Yang Tang, Jinjie He, Yeting Hu, Xiangxing Kong, Fei Teng, Xiangrui Liu, Ying Yuan and Kefeng DingCancer Biology & Medicine February 2022, 19 (2) 213-228; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0532
Fu, Fenfen
- You have accessAssociation between 15 known or potential breast cancer susceptibility genes and breast cancer risks in Chinese womenFenfen Fu, Dongjie Zhang, Li Hu, Senthil Sundaram, Dingge Ying, Ying Zhang, Shuna Fu, Juan Zhang, Lu Yao, Ye Xu and Yuntao XieCancer Biology & Medicine February 2022, 19 (2) 253-262; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0358
Fu, Shuna
- You have accessAssociation between 15 known or potential breast cancer susceptibility genes and breast cancer risks in Chinese womenFenfen Fu, Dongjie Zhang, Li Hu, Senthil Sundaram, Dingge Ying, Ying Zhang, Shuna Fu, Juan Zhang, Lu Yao, Ye Xu and Yuntao XieCancer Biology & Medicine February 2022, 19 (2) 253-262; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0358
Fu, Weiqi
- You have accessTumorigenic bacteria in colorectal cancer: mechanisms and treatmentsSha Li, Jinyi Liu, Xiangjin Zheng, Liwen Ren, Yihui Yang, Wan Li, Weiqi Fu, Jinhua Wang and Guanhua DuCancer Biology & Medicine February 2022, 19 (2) 147-162; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0651
G
Ge, Jingyu
- You have accessThe advance of adjuvant treatment for triple-negative breast cancerJingyu Ge, Wenjia Zuo, Yiyu Chen, Zhiming Shao and Keda YuCancer Biology & Medicine February 2022, 19 (2) 187-201; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0752
Guo, Yuchen
- You have accessA CRISPR-Cas9 screen shows the combination efficacy of lenvatinib plus epidermal growth factor receptor inhibitors for treatment of liver cancerYuchen Guo, Yangyang Zhou and Wenxin QinCancer Biology & Medicine February 2022, 19 (2) 136-139; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0520
H
Hao, Qian
- You have accessThe emerging role of long noncoding RNA RMRP in cancer development and targeted therapyQian Hao and Xiang ZhouCancer Biology & Medicine February 2022, 19 (2) 140-146; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0577
He, Jinjie
- You have accessEfficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancerXinyi Zhou, Qian Xiao, Dongliang Fu, Haochen Zhang, Yang Tang, Jinjie He, Yeting Hu, Xiangxing Kong, Fei Teng, Xiangrui Liu, Ying Yuan and Kefeng DingCancer Biology & Medicine February 2022, 19 (2) 213-228; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0532
Hou, Chunyu
- You have accessHighlighted multi-modifications of enzymes: a novel succinylation mediated by histone acetyltransferase 1 in tumorsXiaodong Zhang, Chunyu Hou and Guang YangCancer Biology & Medicine February 2022, 19 (2) 133-135; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0533
Hu, Li
- You have accessAssociation between 15 known or potential breast cancer susceptibility genes and breast cancer risks in Chinese womenFenfen Fu, Dongjie Zhang, Li Hu, Senthil Sundaram, Dingge Ying, Ying Zhang, Shuna Fu, Juan Zhang, Lu Yao, Ye Xu and Yuntao XieCancer Biology & Medicine February 2022, 19 (2) 253-262; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0358
Hu, Yeting
- You have accessEfficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancerXinyi Zhou, Qian Xiao, Dongliang Fu, Haochen Zhang, Yang Tang, Jinjie He, Yeting Hu, Xiangxing Kong, Fei Teng, Xiangrui Liu, Ying Yuan and Kefeng DingCancer Biology & Medicine February 2022, 19 (2) 213-228; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0532
J
Ji, Xiaowei
- You have accessGlobal pattern and trends of colorectal cancer survival: a systematic review of population-based registration dataYufei Jiang, Huiyun Yuan, Zhuoying Li, Xiaowei Ji, Qiuming Shen, Jiayi Tuo, Jinghao Bi, Honglan Li and Yongbing XiangCancer Biology & Medicine February 2022, 19 (2) 175-186; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0634
Jiang, Yufei
- You have accessGlobal pattern and trends of colorectal cancer survival: a systematic review of population-based registration dataYufei Jiang, Huiyun Yuan, Zhuoying Li, Xiaowei Ji, Qiuming Shen, Jiayi Tuo, Jinghao Bi, Honglan Li and Yongbing XiangCancer Biology & Medicine February 2022, 19 (2) 175-186; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0634
K
Kong, Xiangxing
- You have accessEfficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancerXinyi Zhou, Qian Xiao, Dongliang Fu, Haochen Zhang, Yang Tang, Jinjie He, Yeting Hu, Xiangxing Kong, Fei Teng, Xiangrui Liu, Ying Yuan and Kefeng DingCancer Biology & Medicine February 2022, 19 (2) 213-228; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0532
L
Le, Baoyu
- You have accessSystematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cellsYu Yu, Minzhen Tao, Libin Xu, Lei Cao, Baoyu Le, Na An, Jilin Dong, Yajie Xu, Baoxing Yang, Wei Li, Bing Liu, Qiong Wu, Yinying Lu, Zhen Xie and Xiaohua LianCancer Biology & Medicine February 2022, 19 (2) 229-252; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0560
Lei, Qunying
- You have accessCancer metabolism and dietary interventionsLin Qian, Fan Zhang, Miao Yin and Qunying LeiCancer Biology & Medicine February 2022, 19 (2) 163-174; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0461
Li, Honglan
- You have accessGlobal pattern and trends of colorectal cancer survival: a systematic review of population-based registration dataYufei Jiang, Huiyun Yuan, Zhuoying Li, Xiaowei Ji, Qiuming Shen, Jiayi Tuo, Jinghao Bi, Honglan Li and Yongbing XiangCancer Biology & Medicine February 2022, 19 (2) 175-186; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0634
Li, Sha
- You have accessTumorigenic bacteria in colorectal cancer: mechanisms and treatmentsSha Li, Jinyi Liu, Xiangjin Zheng, Liwen Ren, Yihui Yang, Wan Li, Weiqi Fu, Jinhua Wang and Guanhua DuCancer Biology & Medicine February 2022, 19 (2) 147-162; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0651
Li, Wan
- You have accessTumorigenic bacteria in colorectal cancer: mechanisms and treatmentsSha Li, Jinyi Liu, Xiangjin Zheng, Liwen Ren, Yihui Yang, Wan Li, Weiqi Fu, Jinhua Wang and Guanhua DuCancer Biology & Medicine February 2022, 19 (2) 147-162; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0651
Li, Wei
- You have accessSystematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cellsYu Yu, Minzhen Tao, Libin Xu, Lei Cao, Baoyu Le, Na An, Jilin Dong, Yajie Xu, Baoxing Yang, Wei Li, Bing Liu, Qiong Wu, Yinying Lu, Zhen Xie and Xiaohua LianCancer Biology & Medicine February 2022, 19 (2) 229-252; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0560
Li, Zhuoying
- You have accessGlobal pattern and trends of colorectal cancer survival: a systematic review of population-based registration dataYufei Jiang, Huiyun Yuan, Zhuoying Li, Xiaowei Ji, Qiuming Shen, Jiayi Tuo, Jinghao Bi, Honglan Li and Yongbing XiangCancer Biology & Medicine February 2022, 19 (2) 175-186; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0634
Lian, Xiaohua
- You have accessSystematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cellsYu Yu, Minzhen Tao, Libin Xu, Lei Cao, Baoyu Le, Na An, Jilin Dong, Yajie Xu, Baoxing Yang, Wei Li, Bing Liu, Qiong Wu, Yinying Lu, Zhen Xie and Xiaohua LianCancer Biology & Medicine February 2022, 19 (2) 229-252; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0560
Liu, Bing
- You have accessSystematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cellsYu Yu, Minzhen Tao, Libin Xu, Lei Cao, Baoyu Le, Na An, Jilin Dong, Yajie Xu, Baoxing Yang, Wei Li, Bing Liu, Qiong Wu, Yinying Lu, Zhen Xie and Xiaohua LianCancer Biology & Medicine February 2022, 19 (2) 229-252; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0560
Liu, Jinyi
- You have accessTumorigenic bacteria in colorectal cancer: mechanisms and treatmentsSha Li, Jinyi Liu, Xiangjin Zheng, Liwen Ren, Yihui Yang, Wan Li, Weiqi Fu, Jinhua Wang and Guanhua DuCancer Biology & Medicine February 2022, 19 (2) 147-162; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0651
Liu, Xiangrui
- You have accessEfficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancerXinyi Zhou, Qian Xiao, Dongliang Fu, Haochen Zhang, Yang Tang, Jinjie He, Yeting Hu, Xiangxing Kong, Fei Teng, Xiangrui Liu, Ying Yuan and Kefeng DingCancer Biology & Medicine February 2022, 19 (2) 213-228; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0532
Lu, Yinying
- You have accessSystematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cellsYu Yu, Minzhen Tao, Libin Xu, Lei Cao, Baoyu Le, Na An, Jilin Dong, Yajie Xu, Baoxing Yang, Wei Li, Bing Liu, Qiong Wu, Yinying Lu, Zhen Xie and Xiaohua LianCancer Biology & Medicine February 2022, 19 (2) 229-252; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0560
M
Manohar, Poorni M.
- You have accessUpdates in endocrine therapy for metastatic breast cancerPoorni M. Manohar and Nancy E. DavidsonCancer Biology & Medicine February 2022, 19 (2) 202-212; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0255
Q
Qian, Lin
- You have accessCancer metabolism and dietary interventionsLin Qian, Fan Zhang, Miao Yin and Qunying LeiCancer Biology & Medicine February 2022, 19 (2) 163-174; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0461
Qin, Wenxin
- You have accessA CRISPR-Cas9 screen shows the combination efficacy of lenvatinib plus epidermal growth factor receptor inhibitors for treatment of liver cancerYuchen Guo, Yangyang Zhou and Wenxin QinCancer Biology & Medicine February 2022, 19 (2) 136-139; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0520
R
Ren, Liwen
- You have accessTumorigenic bacteria in colorectal cancer: mechanisms and treatmentsSha Li, Jinyi Liu, Xiangjin Zheng, Liwen Ren, Yihui Yang, Wan Li, Weiqi Fu, Jinhua Wang and Guanhua DuCancer Biology & Medicine February 2022, 19 (2) 147-162; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0651
S
Shao, Zhiming
- You have accessThe advance of adjuvant treatment for triple-negative breast cancerJingyu Ge, Wenjia Zuo, Yiyu Chen, Zhiming Shao and Keda YuCancer Biology & Medicine February 2022, 19 (2) 187-201; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0752
Shen, Qiuming
- You have accessGlobal pattern and trends of colorectal cancer survival: a systematic review of population-based registration dataYufei Jiang, Huiyun Yuan, Zhuoying Li, Xiaowei Ji, Qiuming Shen, Jiayi Tuo, Jinghao Bi, Honglan Li and Yongbing XiangCancer Biology & Medicine February 2022, 19 (2) 175-186; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0634
Sundaram, Senthil
- You have accessAssociation between 15 known or potential breast cancer susceptibility genes and breast cancer risks in Chinese womenFenfen Fu, Dongjie Zhang, Li Hu, Senthil Sundaram, Dingge Ying, Ying Zhang, Shuna Fu, Juan Zhang, Lu Yao, Ye Xu and Yuntao XieCancer Biology & Medicine February 2022, 19 (2) 253-262; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0358
T
Tan, Yinuo
- You have accessErratum to A truncated protein product of the germline variant of the DUOX2 gene leads to adenomatous polyposisMengyuan Yang, Yingxin Zhao, Yuwei Ding, Juan Wang, Yinuo Tan, Dong Xu and Ying YuanCancer Biology & Medicine February 2022, 19 (2) 263; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.1213
Tang, Yang
- You have accessEfficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancerXinyi Zhou, Qian Xiao, Dongliang Fu, Haochen Zhang, Yang Tang, Jinjie He, Yeting Hu, Xiangxing Kong, Fei Teng, Xiangrui Liu, Ying Yuan and Kefeng DingCancer Biology & Medicine February 2022, 19 (2) 213-228; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0532
Tao, Minzhen
- You have accessSystematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cellsYu Yu, Minzhen Tao, Libin Xu, Lei Cao, Baoyu Le, Na An, Jilin Dong, Yajie Xu, Baoxing Yang, Wei Li, Bing Liu, Qiong Wu, Yinying Lu, Zhen Xie and Xiaohua LianCancer Biology & Medicine February 2022, 19 (2) 229-252; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0560
Teng, Fei
- You have accessEfficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancerXinyi Zhou, Qian Xiao, Dongliang Fu, Haochen Zhang, Yang Tang, Jinjie He, Yeting Hu, Xiangxing Kong, Fei Teng, Xiangrui Liu, Ying Yuan and Kefeng DingCancer Biology & Medicine February 2022, 19 (2) 213-228; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0532
Tuo, Jiayi
- You have accessGlobal pattern and trends of colorectal cancer survival: a systematic review of population-based registration dataYufei Jiang, Huiyun Yuan, Zhuoying Li, Xiaowei Ji, Qiuming Shen, Jiayi Tuo, Jinghao Bi, Honglan Li and Yongbing XiangCancer Biology & Medicine February 2022, 19 (2) 175-186; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0634
W
Wang, Jinhua
- You have accessTumorigenic bacteria in colorectal cancer: mechanisms and treatmentsSha Li, Jinyi Liu, Xiangjin Zheng, Liwen Ren, Yihui Yang, Wan Li, Weiqi Fu, Jinhua Wang and Guanhua DuCancer Biology & Medicine February 2022, 19 (2) 147-162; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0651
Wang, Juan
- You have accessErratum to A truncated protein product of the germline variant of the DUOX2 gene leads to adenomatous polyposisMengyuan Yang, Yingxin Zhao, Yuwei Ding, Juan Wang, Yinuo Tan, Dong Xu and Ying YuanCancer Biology & Medicine February 2022, 19 (2) 263; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.1213
Wu, Qiong
- You have accessSystematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cellsYu Yu, Minzhen Tao, Libin Xu, Lei Cao, Baoyu Le, Na An, Jilin Dong, Yajie Xu, Baoxing Yang, Wei Li, Bing Liu, Qiong Wu, Yinying Lu, Zhen Xie and Xiaohua LianCancer Biology & Medicine February 2022, 19 (2) 229-252; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0560
X
Xiang, Yongbing
- You have accessGlobal pattern and trends of colorectal cancer survival: a systematic review of population-based registration dataYufei Jiang, Huiyun Yuan, Zhuoying Li, Xiaowei Ji, Qiuming Shen, Jiayi Tuo, Jinghao Bi, Honglan Li and Yongbing XiangCancer Biology & Medicine February 2022, 19 (2) 175-186; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0634
Xiao, Qian
- You have accessEfficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancerXinyi Zhou, Qian Xiao, Dongliang Fu, Haochen Zhang, Yang Tang, Jinjie He, Yeting Hu, Xiangxing Kong, Fei Teng, Xiangrui Liu, Ying Yuan and Kefeng DingCancer Biology & Medicine February 2022, 19 (2) 213-228; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0532
Xie, Yuntao
- You have accessAssociation between 15 known or potential breast cancer susceptibility genes and breast cancer risks in Chinese womenFenfen Fu, Dongjie Zhang, Li Hu, Senthil Sundaram, Dingge Ying, Ying Zhang, Shuna Fu, Juan Zhang, Lu Yao, Ye Xu and Yuntao XieCancer Biology & Medicine February 2022, 19 (2) 253-262; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0358
Xie, Zhen
- You have accessSystematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cellsYu Yu, Minzhen Tao, Libin Xu, Lei Cao, Baoyu Le, Na An, Jilin Dong, Yajie Xu, Baoxing Yang, Wei Li, Bing Liu, Qiong Wu, Yinying Lu, Zhen Xie and Xiaohua LianCancer Biology & Medicine February 2022, 19 (2) 229-252; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0560
Xu, Dong
- You have accessErratum to A truncated protein product of the germline variant of the DUOX2 gene leads to adenomatous polyposisMengyuan Yang, Yingxin Zhao, Yuwei Ding, Juan Wang, Yinuo Tan, Dong Xu and Ying YuanCancer Biology & Medicine February 2022, 19 (2) 263; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.1213
Xu, Libin
- You have accessSystematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cellsYu Yu, Minzhen Tao, Libin Xu, Lei Cao, Baoyu Le, Na An, Jilin Dong, Yajie Xu, Baoxing Yang, Wei Li, Bing Liu, Qiong Wu, Yinying Lu, Zhen Xie and Xiaohua LianCancer Biology & Medicine February 2022, 19 (2) 229-252; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0560
Xu, Yajie
- You have accessSystematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cellsYu Yu, Minzhen Tao, Libin Xu, Lei Cao, Baoyu Le, Na An, Jilin Dong, Yajie Xu, Baoxing Yang, Wei Li, Bing Liu, Qiong Wu, Yinying Lu, Zhen Xie and Xiaohua LianCancer Biology & Medicine February 2022, 19 (2) 229-252; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0560
Xu, Ye
- You have accessAssociation between 15 known or potential breast cancer susceptibility genes and breast cancer risks in Chinese womenFenfen Fu, Dongjie Zhang, Li Hu, Senthil Sundaram, Dingge Ying, Ying Zhang, Shuna Fu, Juan Zhang, Lu Yao, Ye Xu and Yuntao XieCancer Biology & Medicine February 2022, 19 (2) 253-262; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0358
Y
Yang, Baoxing
- You have accessSystematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cellsYu Yu, Minzhen Tao, Libin Xu, Lei Cao, Baoyu Le, Na An, Jilin Dong, Yajie Xu, Baoxing Yang, Wei Li, Bing Liu, Qiong Wu, Yinying Lu, Zhen Xie and Xiaohua LianCancer Biology & Medicine February 2022, 19 (2) 229-252; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0560
Yang, Guang
- You have accessHighlighted multi-modifications of enzymes: a novel succinylation mediated by histone acetyltransferase 1 in tumorsXiaodong Zhang, Chunyu Hou and Guang YangCancer Biology & Medicine February 2022, 19 (2) 133-135; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0533
Yang, Mengyuan
- You have accessErratum to A truncated protein product of the germline variant of the DUOX2 gene leads to adenomatous polyposisMengyuan Yang, Yingxin Zhao, Yuwei Ding, Juan Wang, Yinuo Tan, Dong Xu and Ying YuanCancer Biology & Medicine February 2022, 19 (2) 263; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.1213
Yang, Yihui
- You have accessTumorigenic bacteria in colorectal cancer: mechanisms and treatmentsSha Li, Jinyi Liu, Xiangjin Zheng, Liwen Ren, Yihui Yang, Wan Li, Weiqi Fu, Jinhua Wang and Guanhua DuCancer Biology & Medicine February 2022, 19 (2) 147-162; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0651
Yao, Lu
- You have accessAssociation between 15 known or potential breast cancer susceptibility genes and breast cancer risks in Chinese womenFenfen Fu, Dongjie Zhang, Li Hu, Senthil Sundaram, Dingge Ying, Ying Zhang, Shuna Fu, Juan Zhang, Lu Yao, Ye Xu and Yuntao XieCancer Biology & Medicine February 2022, 19 (2) 253-262; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0358
Yin, Miao
- You have accessCancer metabolism and dietary interventionsLin Qian, Fan Zhang, Miao Yin and Qunying LeiCancer Biology & Medicine February 2022, 19 (2) 163-174; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0461
Ying, Dingge
- You have accessAssociation between 15 known or potential breast cancer susceptibility genes and breast cancer risks in Chinese womenFenfen Fu, Dongjie Zhang, Li Hu, Senthil Sundaram, Dingge Ying, Ying Zhang, Shuna Fu, Juan Zhang, Lu Yao, Ye Xu and Yuntao XieCancer Biology & Medicine February 2022, 19 (2) 253-262; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0358
Yu, Keda
- You have accessThe advance of adjuvant treatment for triple-negative breast cancerJingyu Ge, Wenjia Zuo, Yiyu Chen, Zhiming Shao and Keda YuCancer Biology & Medicine February 2022, 19 (2) 187-201; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0752
Yu, Yu
- You have accessSystematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cellsYu Yu, Minzhen Tao, Libin Xu, Lei Cao, Baoyu Le, Na An, Jilin Dong, Yajie Xu, Baoxing Yang, Wei Li, Bing Liu, Qiong Wu, Yinying Lu, Zhen Xie and Xiaohua LianCancer Biology & Medicine February 2022, 19 (2) 229-252; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0560
Yuan, Huiyun
- You have accessGlobal pattern and trends of colorectal cancer survival: a systematic review of population-based registration dataYufei Jiang, Huiyun Yuan, Zhuoying Li, Xiaowei Ji, Qiuming Shen, Jiayi Tuo, Jinghao Bi, Honglan Li and Yongbing XiangCancer Biology & Medicine February 2022, 19 (2) 175-186; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0634
Yuan, Ying
- You have accessEfficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancerXinyi Zhou, Qian Xiao, Dongliang Fu, Haochen Zhang, Yang Tang, Jinjie He, Yeting Hu, Xiangxing Kong, Fei Teng, Xiangrui Liu, Ying Yuan and Kefeng DingCancer Biology & Medicine February 2022, 19 (2) 213-228; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0532
- You have accessErratum to A truncated protein product of the germline variant of the DUOX2 gene leads to adenomatous polyposisMengyuan Yang, Yingxin Zhao, Yuwei Ding, Juan Wang, Yinuo Tan, Dong Xu and Ying YuanCancer Biology & Medicine February 2022, 19 (2) 263; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.1213
Z
Zhang, Dongjie
- You have accessAssociation between 15 known or potential breast cancer susceptibility genes and breast cancer risks in Chinese womenFenfen Fu, Dongjie Zhang, Li Hu, Senthil Sundaram, Dingge Ying, Ying Zhang, Shuna Fu, Juan Zhang, Lu Yao, Ye Xu and Yuntao XieCancer Biology & Medicine February 2022, 19 (2) 253-262; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0358
Zhang, Fan
- You have accessCancer metabolism and dietary interventionsLin Qian, Fan Zhang, Miao Yin and Qunying LeiCancer Biology & Medicine February 2022, 19 (2) 163-174; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0461
Zhang, Haochen
- You have accessEfficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancerXinyi Zhou, Qian Xiao, Dongliang Fu, Haochen Zhang, Yang Tang, Jinjie He, Yeting Hu, Xiangxing Kong, Fei Teng, Xiangrui Liu, Ying Yuan and Kefeng DingCancer Biology & Medicine February 2022, 19 (2) 213-228; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0532
Zhang, Juan
- You have accessAssociation between 15 known or potential breast cancer susceptibility genes and breast cancer risks in Chinese womenFenfen Fu, Dongjie Zhang, Li Hu, Senthil Sundaram, Dingge Ying, Ying Zhang, Shuna Fu, Juan Zhang, Lu Yao, Ye Xu and Yuntao XieCancer Biology & Medicine February 2022, 19 (2) 253-262; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0358
Zhang, Xiaodong
- You have accessHighlighted multi-modifications of enzymes: a novel succinylation mediated by histone acetyltransferase 1 in tumorsXiaodong Zhang, Chunyu Hou and Guang YangCancer Biology & Medicine February 2022, 19 (2) 133-135; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0533
Zhang, Ying
- You have accessAssociation between 15 known or potential breast cancer susceptibility genes and breast cancer risks in Chinese womenFenfen Fu, Dongjie Zhang, Li Hu, Senthil Sundaram, Dingge Ying, Ying Zhang, Shuna Fu, Juan Zhang, Lu Yao, Ye Xu and Yuntao XieCancer Biology & Medicine February 2022, 19 (2) 253-262; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0358
Zhao, Yingxin
- You have accessErratum to A truncated protein product of the germline variant of the DUOX2 gene leads to adenomatous polyposisMengyuan Yang, Yingxin Zhao, Yuwei Ding, Juan Wang, Yinuo Tan, Dong Xu and Ying YuanCancer Biology & Medicine February 2022, 19 (2) 263; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.1213
Zheng, Xiangjin
- You have accessTumorigenic bacteria in colorectal cancer: mechanisms and treatmentsSha Li, Jinyi Liu, Xiangjin Zheng, Liwen Ren, Yihui Yang, Wan Li, Weiqi Fu, Jinhua Wang and Guanhua DuCancer Biology & Medicine February 2022, 19 (2) 147-162; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0651
Zhou, Xiang
- You have accessThe emerging role of long noncoding RNA RMRP in cancer development and targeted therapyQian Hao and Xiang ZhouCancer Biology & Medicine February 2022, 19 (2) 140-146; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0577
Zhou, Xinyi
- You have accessEfficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancerXinyi Zhou, Qian Xiao, Dongliang Fu, Haochen Zhang, Yang Tang, Jinjie He, Yeting Hu, Xiangxing Kong, Fei Teng, Xiangrui Liu, Ying Yuan and Kefeng DingCancer Biology & Medicine February 2022, 19 (2) 213-228; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0532
Zhou, Yangyang
- You have accessA CRISPR-Cas9 screen shows the combination efficacy of lenvatinib plus epidermal growth factor receptor inhibitors for treatment of liver cancerYuchen Guo, Yangyang Zhou and Wenxin QinCancer Biology & Medicine February 2022, 19 (2) 136-139; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0520
Zuo, Wenjia
- You have accessThe advance of adjuvant treatment for triple-negative breast cancerJingyu Ge, Wenjia Zuo, Yiyu Chen, Zhiming Shao and Keda YuCancer Biology & Medicine February 2022, 19 (2) 187-201; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0752
In this issue
